Candida thyroiditis--treated with 5 fluoro-cytosine.

A case of Candida thyroiditis in a patient with Goodpasture's Syndrome is described. Factors predisposing to the infection were neutropenia and the concomitant use of antibiotics and immunosuppressive agents. The patient was successfully treated with 5 fluoro-cytosine (5 f-c) and surgical drainage.

[1]  F. Firkin.  Therapy of deep-seated fungal infections with 5-fluorocytosine. , 1974, Australian and New Zealand journal of medicine.

[2]  R. Meyer,et al.  Fatal aplastic anemia resulting from flucytosine. , 1974, JAMA.

[3]  A. Levine,et al.  Fungemia with compromised host resistance. A study of 70 cases. , 1974, Annals of internal medicine.

[4]  E. Block,et al.  Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. , 1974, Annals of internal medicine.

[5]  W. Jubiz,et al.  Thyroid abnormalities in renal failure. A study of 53 patients on chronic hemodialysis. , 1973, Annals of internal medicine.

[6]  P. Klite,et al.  5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. , 1972, Annals of internal medicine.

[7]  J. Lukens,et al.  Thyrotoxicosis associated with Aspergillus thyroiditis in chronic granulomatous disease. , 1972, The Journal of pediatrics.

[8]  M. Finland,et al.  Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. , 1970, Archives of internal medicine.

[9]  J. Remington,et al.  The compromised host and infection. II. Deep fungal infection. , 1969, The Journal of infectious diseases.

[10]  S. Shadomy.  In vitro studies with 5-fluorocytosine. , 1969, Applied microbiology.

[11]  D. Rifkind,et al.  Systemic fungal infections complicating renal transplantation and immunosuppressive therapy: Clinical, microbiologic, neurologic and pathologic features , 1967 .

[12]  J. Hazard.  Thyroiditis: A Review: Part II , 1955 .